Baldwin J E, Killin S J, Pratt A J, Sutherland J D, Turner N J, Crabbe M J, Abraham E P, Willis A C
J Antibiot (Tokyo). 1987 May;40(5):652-9. doi: 10.7164/antibiotics.40.652.
Isopenicillin N synthetase (IPS) cloned from Cephalosporium acremonium has been isolated from transformed Escherichia coli and purified to homogeneity. The resulting, abundant, recombinant protein, whilst undergoing slightly different N-terminal processing to that observed for the fungally-derived protein, has identical kinetics for the conversion of LLD-aminoadipoyl-cysteinyl-valine to isopenicillin N. Recombinant IPS converts analogue substrates into unusual beta-lactam antibiotics in exactly the same way as the fungal protein.
从顶头孢霉克隆的异青霉素N合成酶(IPS)已从转化的大肠杆菌中分离出来并纯化至同质。所得的大量重组蛋白,虽然其N端加工过程与真菌来源的蛋白略有不同,但将LLD-氨基己二酰-半胱氨酰-缬氨酸转化为异青霉素N的动力学相同。重组IPS将类似底物转化为不寻常的β-内酰胺抗生素的方式与真菌蛋白完全相同。